These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Whyte LS; Ryberg E; Sims NA; Ridge SA; Mackie K; Greasley PJ; Ross RA; Rogers MJ Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16511-6. PubMed ID: 19805329 [TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation. Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906 [TBL] [Abstract][Full Text] [Related]
8. GluK1 inhibits calcium dependent and independent transmitter release at associational/commissural synapses in area CA3 of the hippocampus. Salmen B; Beed PS; Ozdogan T; Maier N; Johenning FW; Winterer J; Breustedt J; Schmitz D Hippocampus; 2012 Jan; 22(1):57-68. PubMed ID: 20848601 [TBL] [Abstract][Full Text] [Related]
9. Synaptic Integration of Subquantal Neurotransmission by Colocalized G Protein-Coupled Receptors in Presynaptic Terminals. Church E; Hamid E; Zurawski Z; Potcoava M; Flores-Barrera E; Caballero A; Tseng KY; Alford S J Neurosci; 2022 Feb; 42(6):980-1000. PubMed ID: 34949691 [TBL] [Abstract][Full Text] [Related]
10. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801 [TBL] [Abstract][Full Text] [Related]
11. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827 [TBL] [Abstract][Full Text] [Related]
12. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. Chiba T; Ueno S; Obara Y; Nakahata N J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165 [TBL] [Abstract][Full Text] [Related]
14. The number and organization of Ca2+ channels in the active zone shapes neurotransmitter release from Schaffer collateral synapses. Scimemi A; Diamond JS J Neurosci; 2012 Dec; 32(50):18157-76. PubMed ID: 23238730 [TBL] [Abstract][Full Text] [Related]
15. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Nevalainen T; Irving AJ Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712 [TBL] [Abstract][Full Text] [Related]
16. Presynaptic calcium stores contribute to nicotine-elicited potentiation of evoked synaptic transmission at CA3-CA1 connections in the neonatal rat hippocampus. Le Magueresse C; Cherubini E Hippocampus; 2007; 17(4):316-25. PubMed ID: 17330864 [TBL] [Abstract][Full Text] [Related]
17. Bidirectional modulation of glutamatergic synaptic transmission by metabotropic glutamate type 7 receptors at Schaffer collateral-CA1 hippocampal synapses. Martín R; Ferrero JJ; Collado-Alsina A; Aguado C; Luján R; Torres M; Sánchez-Prieto J J Physiol; 2018 Mar; 596(5):921-940. PubMed ID: 29280494 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors. Manduca A; Buzzelli V; Rava A; Feo A; Carbone E; Schiavi S; Peruzzi B; D'Oria V; Pezzullo M; Pasquadibisceglie A; Polticelli F; Micale V; Kuchar M; Trezza V Pharmacol Res; 2024 May; 203():107176. PubMed ID: 38583687 [TBL] [Abstract][Full Text] [Related]